BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 16953219)

  • 1. Transgenic overexpression of IGF-IR disrupts mammary ductal morphogenesis and induces tumor formation.
    Jones RA; Campbell CI; Gunther EJ; Chodosh LA; Petrik JJ; Khokha R; Moorehead RA
    Oncogene; 2007 Mar; 26(11):1636-44. PubMed ID: 16953219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a novel primary mammary tumor cell line reveals that cyclin D1 is regulated by the type I insulin-like growth factor receptor.
    Jones RA; Campbell CI; Petrik JJ; Moorehead RA
    Mol Cancer Res; 2008 May; 6(5):819-28. PubMed ID: 18505926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preneoplastic changes persist after IGF-IR downregulation and tumor regression.
    Jones RA; Petrik JJ; Moorehead RA
    Oncogene; 2010 Aug; 29(34):4779-86. PubMed ID: 20543862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of the colony-stimulating factor (CSF-1) and/or its receptor c-fms in mammary glands of transgenic mice results in hyperplasia and tumor formation.
    Kirma N; Luthra R; Jones J; Liu YG; Nair HB; Mandava U; Tekmal RR
    Cancer Res; 2004 Jun; 64(12):4162-70. PubMed ID: 15205327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SirT1 modulates the estrogen-insulin-like growth factor-1 signaling for postnatal development of mammary gland in mice.
    Li H; Rajendran GK; Liu N; Ware C; Rubin BP; Gu Y
    Breast Cancer Res; 2007; 9(1):R1. PubMed ID: 17201918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversibility and recurrence of IGF-IR-induced mammary tumors.
    Jones RA; Campbell CI; Wood GA; Petrik JJ; Moorehead RA
    Oncogene; 2009 May; 28(21):2152-62. PubMed ID: 19377512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
    Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor development by transgenic expression of a constitutively active insulin-like growth factor I receptor.
    Carboni JM; Lee AV; Hadsell DL; Rowley BR; Lee FY; Bol DK; Camuso AE; Gottardis M; Greer AF; Ho CP; Hurlburt W; Li A; Saulnier M; Velaparthi U; Wang C; Wen ML; Westhouse RA; Wittman M; Zimmermann K; Rupnow BA; Wong TW
    Cancer Res; 2005 May; 65(9):3781-7. PubMed ID: 15867374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen promotes mammary tumor development in C3(1)/SV40 large T-antigen transgenic mice: paradoxical loss of estrogen receptoralpha expression during tumor progression.
    Yoshidome K; Shibata MA; Couldrey C; Korach KS; Green JE
    Cancer Res; 2000 Dec; 60(24):6901-10. PubMed ID: 11156389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene.
    Torres-Arzayus MI; Font de Mora J; Yuan J; Vazquez F; Bronson R; Rue M; Sellers WR; Brown M
    Cancer Cell; 2004 Sep; 6(3):263-74. PubMed ID: 15380517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced circulating insulin-like growth factor I levels delay the onset of chemically and genetically induced mammary tumors.
    Wu Y; Cui K; Miyoshi K; Hennighausen L; Green JE; Setser J; LeRoith D; Yakar S
    Cancer Res; 2003 Aug; 63(15):4384-8. PubMed ID: 12907608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumors initiated by constitutive Cdk2 activation exhibit transforming growth factor beta resistance and acquire paracrine mitogenic stimulation during progression.
    Corsino P; Davis B; Law M; Chytil A; Forrester E; Nørgaard P; Teoh N; Law B
    Cancer Res; 2007 Apr; 67(7):3135-44. PubMed ID: 17409420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenic overexpression of IGF-II induces spontaneous lung tumors: a model for human lung adenocarcinoma.
    Moorehead RA; Sanchez OH; Baldwin RM; Khokha R
    Oncogene; 2003 Feb; 22(6):853-7. PubMed ID: 12584565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Netrin-1 regulates invasion and migration of mouse mammary epithelial cells overexpressing Cripto-1 in vitro and in vivo.
    Strizzi L; Bianco C; Raafat A; Abdallah W; Chang C; Raafat D; Hirota M; Hamada S; Sun Y; Normanno N; Callahan R; Hinck L; Salomon D
    J Cell Sci; 2005 Oct; 118(Pt 20):4633-43. PubMed ID: 16176936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor receptor as a therapeutic target in head and neck cancer.
    Barnes CJ; Ohshiro K; Rayala SK; El-Naggar AK; Kumar R
    Clin Cancer Res; 2007 Jul; 13(14):4291-9. PubMed ID: 17634559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammary gland specific hEGF receptor transgene expression induces neoplasia and inhibits differentiation.
    Brandt R; Eisenbrandt R; Leenders F; Zschiesche W; Binas B; Juergensen C; Theuring F
    Oncogene; 2000 Apr; 19(17):2129-37. PubMed ID: 10815804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation.
    Turner BC; Haffty BG; Narayanan L; Yuan J; Havre PA; Gumbs AA; Kaplan L; Burgaud JL; Carter D; Baserga R; Glazer PM
    Cancer Res; 1997 Aug; 57(15):3079-83. PubMed ID: 9242428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway.
    Akli S; Van Pelt CS; Bui T; Multani AS; Chang S; Johnson D; Tucker S; Keyomarsi K
    Cancer Res; 2007 Aug; 67(15):7212-22. PubMed ID: 17671189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditional deletion of insulin-like growth factor-I receptor in prostate epithelium.
    Sutherland BW; Knoblaugh SE; Kaplan-Lefko PJ; Wang F; Holzenberger M; Greenberg NM
    Cancer Res; 2008 May; 68(9):3495-504. PubMed ID: 18451178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines.
    Shukla A; Grisouard J; Ehemann V; Hermani A; Enzmann H; Mayer D
    Endocr Relat Cancer; 2009 Jun; 16(2):429-41. PubMed ID: 19153208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.